Assessing therapy response of secreting pineal germ cell tumor on simultaneous 18F-choline PET/MRI

Clinical Nuclear Medicine

Volumn 39, Issue 9, 2014, Pages e387-e388

  Panagiotidis, Emmanouil ^a   Shankar, Ananth ^a   Afaq, Asim ^a   Bomanji, Jamshed ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

18F choline; Germ cell tumor; Pineal tumor; Simultaneous PET MRI; Therapy response

Indexed keywords

CHOLINE F 18; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GADOLINIUM; PHOSPHOLIPID; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CHOLINE; FLUOROMETHYLCHOLINE;

ADULT; BLURRED VISION; CANCER DIAGNOSIS; CANCER TISSUE; CASE REPORT; CONTRAST ENHANCEMENT; DIPLOPIA; DISEASE DURATION; GERM CELL TUMOR; HEADACHE; HUMAN; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PET-MRI SCANNER; PINEAL BODY TUMOR; POSITRON EMISSION TOMOGRAPHY; RADIATION EXPOSURE; SHORT SURVEY; TREATMENT RESPONSE; YOUNG ADULT; ADOLESCENT; ANALOGS AND DERIVATIVES; BRAIN NEOPLASMS; DIAGNOSTIC USE; MULTIMODAL IMAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; PATHOLOGY; PINEAL BODY; PINEALOMA; SCINTISCANNING; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHOLINE; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIMODAL IMAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; PINEAL GLAND; PINEALOMA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TREATMENT OUTCOME;

EID: 84939956567     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0000000000000231     Document Type: Short Survey

References (8)

1. Eiber M, Martinez-Moller A, Souvatzoglou M, et al. Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions. Eur J Nucl Med Mol Imaging. 2011;38:1691-1701.
2. Schmoll HJ. Extragonadal germ cell tumors. Ann Oncol. 2002;13:265-272.
3. Podo F. Tumour phospholipid metabolism. NMR Biomed. 1999;12:413-439.
4. 18F-fluorocholine: a new oncologic PET tracer. J Nucl Med. 2001;42: 1815-1817.
5. 18F]fluoro-D-glucose in tumor imaging with positron emission tomography. Mol Imaging Biol. 2002;4:267-273.
6. Kwee SA, Coel MN, Lim J, et al. Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation. J Neuroimaging. 2004;14:285-289.
7. Kwee SA, Ko JP, Jiang CS, et al. Solitary brain lesions enhancing at MR imaging: evaluation with fluorine 18 fluorocholine PET. Radiology. 2007;244:557-565.
8. 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence. J Nucl Med. 2004;45: 1931-1938.